1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Age-Related Memory Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HZ; Dong, CZ; Gao, XL; Heymans, F; Huang, H; Li, J; Massicot, F; Miezan Ezoulin, JM | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Age-Related Memory Disorders
Article | Year |
---|---|
Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.
Topics: Acetylcholinesterase; Animals; Binding, Competitive; Brain; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Humans; In Vitro Techniques; Male; Maze Learning; Memory; Memory Disorders; Mice; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, G-Protein-Coupled; Scopolamine; Space Perception | 2007 |